Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis

BACKGROUND: Among sarcomas, which are rare cancers with an incidence of <6 per 100.000/year cases, ultra-rare sarcomas have an incidence of approximately ≤1/1,000,000/year cases and altogether account for ~20% of all soft tissue sarcomas (STS) and bone sarcomas. The Italian Sarcoma Group has rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmerini, Emanuela, Sanfilippo, Roberta, Grignani, Giovanni, Buonadonna, Angela, Romanini, Antonella, Badalamenti, Giuseppe, Ferraresi, Virginia, Vincenzi, Bruno, Comandone, Alessandro, Pizzolorusso, Antonio, Brunello, Antonella, Gelsomino, Fabio, De Pas, Tommaso, Ibrahim, Toni, Gurrieri, Lorena, Grosso, Federica, Zanelli, Francesca, Pantaleo, Maria Abbondanza, Milesi, Laura, Ciuffreda, Libero, Ferrari, Vittorio, Marchesi, Emanuela, Quattrini, Irene, Righi, Alberto, Setola, Elisabetta, Carretta, Elisa, Casali, Paolo G., Picci, Piero, Ferrari, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780071/
https://www.ncbi.nlm.nih.gov/pubmed/36568164
http://dx.doi.org/10.3389/fonc.2022.1042479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780071/
https://www.ncbi.nlm.nih.gov/pubmed/36568164
http://dx.doi.org/10.3389/fonc.2022.1042479

Ejemplares similares